Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Headache

glucose, (beta-d)-isomer has been researched along with Headache in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Arena, AC; de Matos Balsalobre, N; Dos Santos, E; Konkiewitz, EC; Leite Kassuya, CA; Mariano Dos Santos, S; Nazari Formagio, AS; Ziff, EB	1
Dobbins, RL; Hompesch, M; Hussey, EK; James, CD; Kapur, A; Mikoshiba, I; Nunez, DJ; O'Connor-Semmes, R; Polli, JW; Smith, GA; Tao, W	1
Hyson, MI	1

Trials

2 trial(s) available for glucose, (beta-d)-isomer and Headache

Article	Year
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus. BMC pharmacology & toxicology, 2013, May-13, Volume: 14 Topics: Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Female; Glucosides; Headache; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Molecular Structure; Pyrazoles; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome	2013
Anticephalgic photoprotective premedicated mask. A report of a successful double-blind placebo-controlled study of a new treatment for headaches with associated frontalis pain and photophobia. Headache, 1998, Volume: 38, Issue:6 Topics: Administration, Topical; Adult; Benzyl Alcohols; Combined Modality Therapy; Double-Blind Method; Female; Glucosides; Headache; Humans; Male; Masks; Middle Aged; Muscles; Placebos	1998

Article

Year

First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus.

BMC pharmacology & toxicology, 2013, May-13, Volume: 14

Topics: Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Electrolytes; Female; Glucosides; Headache; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Molecular Structure; Pyrazoles; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome

2013

Anticephalgic photoprotective premedicated mask. A report of a successful double-blind placebo-controlled study of a new treatment for headaches with associated frontalis pain and photophobia.

Headache, 1998, Volume: 38, Issue:6

Topics: Administration, Topical; Adult; Benzyl Alcohols; Combined Modality Therapy; Double-Blind Method; Female; Glucosides; Headache; Humans; Male; Masks; Middle Aged; Muscles; Placebos

1998

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Headache

Article	Year
Potential anti-arthritic and analgesic properties of essential oil and viridiflorol obtained from Allophylus edulis leaves in mice. Journal of ethnopharmacology, 2023, Jan-30, Volume: 301 Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Dexamethasone; Dihydroxyphenylalanine; Disease Models, Animal; Edema; Formaldehyde; Headache; Hyperalgesia; Inflammation; Mice; Morphine Derivatives; Oils, Volatile; Plant Extracts; Toothache; Tumor Necrosis Factor-alpha; Zymosan	2023

Article

Year

Potential anti-arthritic and analgesic properties of essential oil and viridiflorol obtained from Allophylus edulis leaves in mice.

Journal of ethnopharmacology, 2023, Jan-30, Volume: 301

Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Dexamethasone; Dihydroxyphenylalanine; Disease Models, Animal; Edema; Formaldehyde; Headache; Hyperalgesia; Inflammation; Mice; Morphine Derivatives; Oils, Volatile; Plant Extracts; Toothache; Tumor Necrosis Factor-alpha; Zymosan

2023